Vinorelbine + doxorubicin divided schedule beneficial in breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1282, 2001-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine + doxorubicin vs doxorubicin: QOL no different in breast cancer

Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Vinorelbine in breast cancer

By Bonneterre Jacques Penel Nicolas

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2901-2910

Informa Healthcare

Access to resources Recommend Favorite

Liposomal doxorubicin in combination with vinorelbine shows promise as a treatment for patients with pretreated advanced breast cancer

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Vinorelbine + mitomycin for metastatic breast cancer

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Vinorelbine + mitomycin for metastatic breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite